Q-VD-OPH is a broad-spectrum caspase inhibitor that blocks caspases-3, -7, -8, -9, -10, and -12. It more effectively inhibits apoptosis and is much less cytotoxic than Z-VAD-FMK and Boc-D-FMK.
CAT No: R0812
CAS No:1135695-98-5
Synonyms/Alias:1135695-98-5;Q-VD-OPh;Q-VD-OPh hydrate;QVD-OPH;(3S)-5-(2,6-Difluorophenoxy)-3-[[(2S)-3-methyl-1-oxo-2-[(2-quinolinylcarbonyl)amino]butyl]amino]-4-oxo-pentanoic Acid;(3S)-5-(2,6-difluorophenoxy)-3-[[(2S)-3-methyl-2-(quinoline-2-carbonylamino)butanoyl]amino]-4-oxopentanoic acid;(S)-5-(2,6-Difluorophenoxy)-3-((S)-3-methyl-2-(quinoline-2-carboxamido)butanamido)-4-oxopentanoic acid;N-(2-Quinolyl)valyl-aspartyl-(2,6-difluorophenoxy)methyl ketone;pentanoic acid, 5-(2,6-difluorophenoxy)-3-[[(2S)-3-methyl-1-oxo-2-[(2-quinolinylcarbonyl)amino]butyl]amino]-4-oxo-, (3S)-;Quinoline-Val-Asp-Difluorophenoxymethylketone;MFCD08669741;CHEMBL4237988;SCHEMBL15449978;DTXSID90647322;C26H25F2N3O6;CHEBI:232611;EX-A1093;s7311;AKOS027446655;CCG-269797;CS-6252;AC-31505;BS-14641;FD103285;HY-12305;N-(2-Quinolinyl)valyl-aspartyl (2,6-difluorophenoxy)methyl ketone;(3S)-5-(2,6-DIFLUOROPHENOXY)-3-[(2S)-3-METHYL-2-(QUINOLIN-2-YLFORMAMIDO)BUTANAMIDO]-4-OXOPENTANOIC ACID;(3S)-5-(2,6-Difluorophenoxy)-4-oxo-3-{[N-(quinoline-2-carbonyl)-L-valyl]amino}pentanoic acid;
1. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
3. Myotropic activity of allatostatins in tenebrionid beetles
4. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry
5. Implications of ligand-receptor binding kinetics on GLP-1R signalling
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.